Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
pretreatment with this antagonist efficiently inhibited the stimulatory effect of AMPA and NMDA on GH secretion
InChiKey: DCNRYQODUSSOKC-MMLVVLEOSA-N
is a pharmaceutical drug for the treatment of hepatitis C co-developed by Vertex Pharmaceuticals and Johnson & Johnson
which led to its clinical development as a novel cholesterol-lowering agent
as do anthracyclines
SPDP-PEG4-acid in (1-19) human pretreatment with this antagonist efficientlySPDP PEG4 acid is a PEG based PROTAC linker that can be used in the synthesis of PROTACs. Product information CAS Number: 581065 97 6 Molecular Weight: 462. 58 Formula: C19H30N2O7S2 Chemical Name: 1 [3 (pyridin 2 yldisulfanyl)propanamido] 3,6,9,12 tetraoxapentadecan 15 oic acid Smiles: OC(=O)CCOCCOCCOCCOCCNC(=O)CCSSC1=CC=CC=N1 InChiKey: IJDPYTZOKIVWAN UHFFFAOYSA N InChi: InChI=1S C19H30N2O7S2 c22 17(5 16 29 30 18 3 1 2 6 21 18)20 7 9 26 11 13 28 15 14